Guggenheim Adjusts Price Target on Merck to $122 From $130, Maintains Buy Rating
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
After market 07:48:19 pm | |||
86.40 USD | -1.01% |
|
86.91 | +0.59% |
Feb. 10 | TD Cowen Downgrades Merck & Co. to Hold From Buy, Adjusts Price Target to $100 From $121 | MT |
Feb. 07 | Health Rounds: Vaccine keeps advanced kidney cancer from recurring | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration